Physician profile
Robert M Gerber
NPI 1063474633
$4,986.55
in general payments reported to CMS, 2019-2025
26 companies · $610 in 2025
The $610 reported for 2025 was more than what a typical Podiatrist provider received nationally (typical 2025 total: $260).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,147 · 2020: $335 · 2021: $518 · 2022: $771 · 2023: $1,083 · 2024: $522 · 2025: $610.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,215.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,215.34 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Smith+Nephew, INC. | $678.66 | 2019-2025 | Grafix Pl, Stravix Pl, Stravix |
| Depuy Synthes Sales INC. | $476.55 | 2020-2025 | Minibunion, Motoband |
| Bioventus LLC | $392.54 | 2021-2025 | Exogen Ultrasound Bone Healing System, Exogen Ultrasound Bone Healing System |
| Medtronic, INC. | $292.21 | 2022 | |
| Horizon Therapeutics Plc | $286.27 | 2019-2022 | |
| Organogenesis INC. | $281.55 | 2020-2023 | Puraply |
| Stryker Corporation | $278.09 | 2019-2024 | Prostep Mica, Actishield |
| Melinta Therapeutics, LLC | $243.44 | 2019-2023 | Kimyrsa |
| Integra Lifesciences Corporation | $209.04 | 2020-2023 | Biodrestore, Medihoney, Biofix |
| Osiris Therapeutics INC. | $188.41 | 2019 | |
| Tactile Systems Technology INC | $174.15 | 2021-2025 | Flexitouch Plus, Nimbl |
| Next Science LLC | $168.06 | 2023 | Xperience, Surgx, Blastx |
| Treace Medical Concepts, INC. | $146.24 | 2021 | |
| Paratek Pharmaceuticals, INC. | $143.58 | 2023 | Nuzyra |
| Zimmer Biomet Holdings, INC. | $130.65 | 2019-2022 |
Show all 26 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Extremity Medical | $123.00 | 2024 | |
| Kerecis Limited | $119.42 | 2019 | |
| Boston Scientific Corporation | $116.04 | 2019 | |
| Ortho Dermatologics, A Division of Bausch Health US, LLC | $94.61 | 2022 | |
| Nevro Corp. | $94.37 | 2023 | Senza |
| Mimedx Group, INC. | $88.19 | 2025 | |
| Amgen INC. | $87.27 | 2024 | Krystexxa |
| Osteomed LLC | $69.15 | 2021 | |
| Aroa Biosurgery Incorporated | $67.52 | 2023 | |
| Djo, LLC | $20.32 | 2024 | Cmf |
| Abbott Laboratories | $17.22 | 2023 | Proclaim |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Robert Gerber listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.